2. Briefly stated, a Criminal Complaint was filed by Respondent No.2/M/s Bhardwaj India Private Limited Delhi against Petitioner No. 1/Revacure Lifesciences LLP and its Partners and employees, before the Court of Ld. MM, for deliberately supplying them defective medicines i.e. Docetaxel 20 mg as it had broken glasses and visible foreign particles in the vials, which was noticed after the delivery of the product. Despite this being brought to the notice of the Complainant, the Respondent No.1 failed to take any corrective measures. The Complainant, therefore, sought registration of FIR against the Petitioners for their illegal acts of “manufacturing of product, medicines and injections which may cause serious harm to the patient.”

3. The learned MM under Section 156(3) Cr.P.C. directed registration of FIR against Petitioner No. 1 and its partner and employees, vide Order dated 02.02.2019, which resulted in registration of FIR No. 0053/2019.

4. The Petitioner No. 1 has challenged this Order directing the registration of FIR on the ground that the Complainant has concealed material facts. It is explained that Petitioner No. 1/Revacure owns its manufacturing facility at Jabalpur, Madhya